Physician profile
Peter C Weber
NPI 1063477974
$157,364.91
in general payments reported to CMS, 2019-2025
7 companies · $126K in 2025
The $126K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,401 · 2020: $206 · 2022: $100 · 2023: $127 · 2024: $28K · 2025: $126K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $129K · Travel and Lodging: $25K · Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $128,506.00 |
| Travel and Lodging | $24,575.69 |
| Food and Beverage | $575.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $153,207.21 | 2024-2025 | |
| Olympus Corporation | $2,932.50 | 2019 | |
| Cochlear Americas | $523.42 | 2019-2023 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Grace Medical, INC. | $278.86 | 2024-2025 | |
| Advanced Bionics, LLC | $205.90 | 2020 | |
| Med-El Corporation | $186.78 | 2019-2024 | Adhear Professional Kit, Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Ucb, INC. | $30.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.